spacer
spacer
header
Main Menu
Home
Search
Donate
About OPN
Contact Us
Membership
OPAN
News
Event Calendar
Projects
FREE Cannabis
Jury Power
Medical Maps
Speakers
OPN on the Radio
Legal
Media
Patient/Doctor
Patient Profiles
Online Store
Library
Links
FAQs
Interactive
Email Discussion
Teamspeak
MySpace
OPNTalk Forums
OPNews
OPNews Signup
Recent Issues
Archives
Video
Mikeee Show
Ohio Patients Imprisoned
Randy Brush
In Memoriam
 
Home arrow News arrow OPNews April 2006 arrow Preliminary Results from Sativex® Phase III Multiple Sclerosis spasticity study

Preliminary Results from Sativex® Phase III Multiple Sclerosis spasticity study PDF Print E-mail

Porton Down, UK, 17 March 2006 - GW Pharmaceuticals plc (AIM: GWP) today announces preliminary results from a Phase III study of Sativex® in the relief of spasticity in people with Multiple Sclerosis (MS). This study is one of a number of Phase III studies which are currently taking place to support approval of Sativex across Europe in a range of target indications.

http://production.investis.com/gwp/pressreleases/currentpress/2006-03-17/
[ Back ]
spacer
Join/Donate
via Paypal
GoodSearch: You Search...We Give!
Ohio Medical Marijuana Act

Please contact your legislators regarding the Ohio Medical Marijuana Act!
The Zoretic Patient Defense Fund
To donate to the Zoretic Patient Defense Fund, OPN's patient legal defense fund, simply click the above button. Before entering the amount, please indicate that your donation is for the Zoretic Patient Defense Fund in the Payment For: text box. Thank you for your contribution!
Advertisement
War on Junk
A riotous exploration of prohibition policies, told through the narrative lens of a future America in which the government outlaws junk food in response to widespread obesity. Click on the image to buy this book now. 10% of the purchase price will be donated to OPN.

 
Copyright 2000 - 2005 Miro International Pty Ltd. All rights reserved.
Mambo is Free Software released under the GNU/GPL License.
spacer